299 related articles for article (PubMed ID: 11585982)
41. Characterization of cytochrome P450 expression in human oesophageal mucosa.
Lechevrel M; Casson AG; Wolf CR; Hardie LJ; Flinterman MB; Montesano R; Wild CP
Carcinogenesis; 1999 Feb; 20(2):243-8. PubMed ID: 10069460
[TBL] [Abstract][Full Text] [Related]
42. Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.
Krusekopf S; Roots I; Kleeberg U
Eur J Pharmacol; 2003 Apr; 466(1-2):7-12. PubMed ID: 12679136
[TBL] [Abstract][Full Text] [Related]
43. Cytochrome P450 3A: ontogeny and drug disposition.
de Wildt SN; Kearns GL; Leeder JS; van den Anker JN
Clin Pharmacokinet; 1999 Dec; 37(6):485-505. PubMed ID: 10628899
[TBL] [Abstract][Full Text] [Related]
44. Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.
Yang HY; Lee QP; Rettie AE; Juchau MR
Mol Pharmacol; 1994 Nov; 46(5):922-8. PubMed ID: 7969081
[TBL] [Abstract][Full Text] [Related]
45. Expression and cyclic variability of CYP3A4 and CYP3A7 isoforms in human endometrium and cervix during the menstrual cycle.
Sarkar MA; Vadlamuri V; Ghosh S; Glover DD
Drug Metab Dispos; 2003 Jan; 31(1):1-6. PubMed ID: 12485945
[TBL] [Abstract][Full Text] [Related]
46. Nuclear receptor expression in fetal and pediatric liver: correlation with CYP3A expression.
Vyhlidal CA; Gaedigk R; Leeder JS
Drug Metab Dispos; 2006 Jan; 34(1):131-7. PubMed ID: 16243958
[TBL] [Abstract][Full Text] [Related]
47. A novel female-specific member of the CYP3A gene subfamily in the mouse liver.
Sakuma T; Takai M; Endo Y; Kuroiwa M; Ohara A; Jarukamjorn K; Honma R; Nemoto N
Arch Biochem Biophys; 2000 May; 377(1):153-62. PubMed ID: 10775455
[TBL] [Abstract][Full Text] [Related]
48. Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA.
Villard PH; Seree EM; Re JL; De Meo M; Barra Y; Attolini L; Dumenil G; Catalin J; Durand A; Lacarelle B
Toxicol Appl Pharmacol; 1998 Feb; 148(2):195-204. PubMed ID: 9473526
[TBL] [Abstract][Full Text] [Related]
49. CYP3A gene expression in human gut epithelium.
Kolars JC; Lown KS; Schmiedlin-Ren P; Ghosh M; Fang C; Wrighton SA; Merion RM; Watkins PB
Pharmacogenetics; 1994 Oct; 4(5):247-59. PubMed ID: 7894497
[TBL] [Abstract][Full Text] [Related]
50. Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells.
Maruyama M; Matsunaga T; Harada E; Ohmori S
Biol Pharm Bull; 2007 Nov; 30(11):2091-7. PubMed ID: 17978482
[TBL] [Abstract][Full Text] [Related]
51. Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily.
Rodrigues AD; Roberts EM; Mulford DJ; Yao Y; Ouellet D
Drug Metab Dispos; 1997 May; 25(5):623-30. PubMed ID: 9152603
[TBL] [Abstract][Full Text] [Related]
52. Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies.
Niwa T; Okamoto A; Narita K; Toyota M; Kato K; Kobayashi K; Sasaki S
Arch Biochem Biophys; 2020 Mar; 682():108283. PubMed ID: 32001245
[TBL] [Abstract][Full Text] [Related]
53. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity.
Hakkola J; Pelkonen O; Pasanen M; Raunio H
Crit Rev Toxicol; 1998 Jan; 28(1):35-72. PubMed ID: 9493761
[TBL] [Abstract][Full Text] [Related]
54. Pharmacogenetic determinants of human liver microsomal alfentanil metabolism and the role of cytochrome P450 3A5.
Klees TM; Sheffels P; Thummel KE; Kharasch ED
Anesthesiology; 2005 Mar; 102(3):550-6. PubMed ID: 15731592
[TBL] [Abstract][Full Text] [Related]
55. Selective expression of CYP3A5 and not CYP3A4 in human blood.
Janardan SK; Lown KS; Schmiedlin-Ren P; Thummel KE; Watkins PB
Pharmacogenetics; 1996 Oct; 6(5):379-85. PubMed ID: 8946469
[TBL] [Abstract][Full Text] [Related]
56. Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene.
Gellner K; Eiselt R; Hustert E; Arnold H; Koch I; Haberl M; Deglmann CJ; Burk O; Buntefuss D; Escher S; Bishop C; Koebe HG; Brinkmann U; Klenk HP; Kleine K; Meyer UA; Wojnowski L
Pharmacogenetics; 2001 Mar; 11(2):111-21. PubMed ID: 11266076
[TBL] [Abstract][Full Text] [Related]
57. Role of the liver-enriched transcription factors C/EBP alpha and DBP in the expression of human CYP3A4 and CYP3A7.
Ourlin JC; Jounaïdi Y; Maurel P; Vilarem MJ
J Hepatol; 1997; 26 Suppl 2():54-62. PubMed ID: 9204410
[TBL] [Abstract][Full Text] [Related]
58. Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice.
Cheung C; Yu AM; Chen CS; Krausz KW; Byrd LG; Feigenbaum L; Edwards RJ; Waxman DJ; Gonzalez FJ
J Pharmacol Exp Ther; 2006 Mar; 316(3):1328-34. PubMed ID: 16291874
[TBL] [Abstract][Full Text] [Related]
59. Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues.
McKinnon RA; Burgess WM; Hall PM; Roberts-Thomson SJ; Gonzalez FJ; McManus ME
Gut; 1995 Feb; 36(2):259-67. PubMed ID: 7883227
[TBL] [Abstract][Full Text] [Related]
60. A novel form of mouse cytochrome P450 3A (Cyp3a-16). Its cDNA cloning and expression in fetal liver.
Itoh S; Satoh M; Abe Y; Hashimoto H; Yanagimoto T; Kamataki T
Eur J Biochem; 1994 Dec; 226(3):877-82. PubMed ID: 7813478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]